Phase III Randomized Trial of Radiosensitization with HU vs HU/5-FU/CDDP vs CDDP in Patients with Stage IIB/III/IVA Cervical Cancer with Negative Para-Aortic Nodes
Back to Top
Basic Trial Information
Trial Contact Information
| Phase | Type | Status | Age | Sponsor | Protocol IDs |
|---|---|---|---|---|---|
| Phase III | Treatment | Completed | any age | NCI | GOG-120 GOG-0120 |
Trial Lead Organizations
Gynecologic Oncology Group
| Peter Rose, MD, Protocol chair (Contact information may not be current) |
| ||
Back to Top
